Result Summary for 101468/253
| Protocol ID: | 101468/253 |
| Clinical Study ID: | 101468/253 |
| Official Title: | An open label, single dose, dose rising, multi-centre study to assess the tolerability and pharmacokinetics of Ropinirole Immediate Release in adolescent patients with RLS. |
| Phase: | phase 1 |
| Study Indications or Diseases: |
|
| Generic Name: | ropinirole |
| Trade/Product Name: | Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara |
| Approved Drug Label: | Parkinson's Disease, Restless Leg Syndrome |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
